Corine Ekhart

1.1k total citations
35 papers, 763 citations indexed

About

Corine Ekhart is a scholar working on Pharmacology, Toxicology and Pharmacology. According to data from OpenAlex, Corine Ekhart has authored 35 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Toxicology and 8 papers in Pharmacology. Recurrent topics in Corine Ekhart's work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Corine Ekhart is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (9 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Corine Ekhart collaborates with scholars based in Netherlands, Italy and Türkiye. Corine Ekhart's co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Sjoerd Rodenhuis, Paul H.M. Smits, Eugène van Puijenbroek, Sieta T. de Vries, Florence van Hunsel, Peter G. M. Mol, Petra Denig and Valerie D. Doodeman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Corine Ekhart

33 papers receiving 750 citations

Peers

Countries citing papers authored by Corine Ekhart

Since Specialization

Citations

This map shows the geographic impact of Corine Ekhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corine Ekhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corine Ekhart more than expected).

Fields of papers citing papers by Corine Ekhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corine Ekhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corine Ekhart. The network helps show where Corine Ekhart may publish in the future.

Co-authorship network of co-authors of Corine Ekhart

This figure shows the co-authorship network connecting the top 25 collaborators of Corine Ekhart. A scholar is included among the top collaborators of Corine Ekhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corine Ekhart. Corine Ekhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy 2025 ·Pharmacoepidemiology and Drug Safety ·Florence van Hunsel, (unknown), Misha F. Vrolijk, Corine Ekhart	0
2	Safety Considerations for Natural Products with Adaptogenic and Immunomodulating Activities 2025 ·Pharmaceuticals ·Chen Liang, Herman J. Woerdenbag, Corine Ekhart, Annabella Vitalone, Florence van Hunsel	1
3	Analysis of Adverse Reactions Associated with the Use of Crataegus-Containing Herbal Products 2024 ·Pharmaceuticals ·Herman J. Woerdenbag, (unknown), Corine Ekhart, Martina Schmidt, Annabella Vitalone, Florence van Hunsel	3
4	Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide 2024 ·Drug Safety ·Corine Ekhart, (unknown), (unknown), Souad Skalli, (unknown), Francesca Menniti‐Ippolito, (unknown), (unknown), Herman J. Woerdenbag, Florence van Hunsel	1
5	The Therapeutic Potential of Essential Oils in Managing Inflammatory Skin Conditions: A Scoping Review 2024 ·Pharmaceuticals ·(unknown), Catharina C. M. Schuiling‐Veninga, Florence van Hunsel, Corine Ekhart, Fati̇h Demi̇rci̇, Herman J. Woerdenbag	10
6	Patient Experiences with the Use of Medicinal Cannabis in the Netherlands: A Cohort-Event Monitoring Study 2023 ·SHILAP Revista de lepidopterología ·Corine Ekhart, (unknown), (unknown), Leàn Rolfes, (unknown)	1
7	Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity 2023 ·Pharmaceuticals ·(unknown), Florence van Hunsel, (unknown), Corine Ekhart, Annabella Vitalone, Herman J. Woerdenbag	2
8	Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports 2022 ·Drug Safety ·Corine Ekhart, Florence van Hunsel, Eugène van Puijenbroek, Rebecca E. Chandler, (unknown), H. Taavola, G. Niklas Norén	12
9	Unexpected beneficial effects of drugs: an analysis of cases in the Dutch spontaneous reporting system 2021 ·European Journal of Clinical Pharmacology ·Florence van Hunsel, Corine Ekhart	3
10	Drug-Induced Stuttering: Occurrence and Possible Pathways 2021 ·Frontiers in Psychiatry ·Corine Ekhart, Florence van Hunsel, Peter van Harten, (unknown), (unknown), (unknown)	7
11	Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study 2020 ·Drug Safety ·Sieta T. de Vries, Petra Denig, Corine Ekhart, Peter G. M. Mol, Eugène van Puijenbroek	52
12	Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors 2018 ·Drug Safety ·Corine Ekhart, Florence van Hunsel, (unknown), Sieta T. de Vries, Eugène van Puijenbroek	24
13	First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports 2017 ·Expert Opinion on Drug Safety ·(unknown), Leàn Rolfes, Corine Ekhart, (unknown), Linda Härmark	13
14	Unbearable Pruritus After Withdrawal of (Levo)cetirizine 2016 ·PubMed ·Corine Ekhart, (unknown), Florence van Hunsel	2
15	Pharmacokinetics of Cyclophosphamide and Thiotepa in a Conventional Fractionated High-Dose Regimen Compared With a Novel Simplified Unfractionated Regimen 2009 ·Therapeutic Drug Monitoring ·Corine Ekhart, Sjoerd Rodenhuis, Jos H. Beijnen, Alwin D. R. Huitema	3
16	Polymorphisms of drug‐metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa 2008 ·British Journal of Clinical Pharmacology ·Corine Ekhart, Valerie D. Doodeman, Sjoerd Rodenhuis, Paul H.M. Smits, Jos H. Beijnen, Alwin D. R. Huitema	37
17	Carbamazepine induces bioactivation of cyclophosphamide and thiotepa 2008 ·Cancer Chemotherapy and Pharmacology ·Corine Ekhart, Sjoerd Rodenhuis, Jos H. Beijnen, Alwin D. R. Huitema	9
18	Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin 2008 ·Pharmacogenetics and Genomics ·Corine Ekhart, Sjoerd Rodenhuis, Paul H.M. Smits, Jos H. Beijnen, Alwin D. R. Huitema	49
19	An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment 2008 ·Cancer Treatment Reviews ·Corine Ekhart, Sjoerd Rodenhuis, Paul H.M. Smits, Jos H. Beijnen, Alwin D. R. Huitema	70
20	Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter? 2008 ·Cancer Chemotherapy and Pharmacology ·Corine Ekhart, Sjoerd Rodenhuis, Jan H.M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact